预期的变化:用于监测口服双酸盐患者的新概念
Marian Schini1, Margaret A Paggiosi1, Fatma Gossiel1
1University of Sheffield, United Kingdom.
概括
监测骨质疏松症治疗反应至关重要,因为不坚持. 骨周转指标 (CTX和PINP) 优于骨矿物密度 (BMD) 在使用预期变化方法跟踪口服双酸盐治疗的有效性.
科学领域:
- 内分泌学 在内分泌学.
- 骨质疏松症研究研究
- 药理动力学是什么意思 药理动力学
背景情况:
- 口服双酸盐是骨质疏松症的标准治疗方法.
- 患者坚持治疗显著影响治疗疗效.
- 目前用于口服双酸盐治疗的监测方法可能无法准确反映患者的反应.
研究的目的:
- 评估骨矿物质密度 (BMD) 和骨循环标记 (BTMs) 以监测骨质疏松症治疗.
- 引入和验证一种"预期变化"方法来评估治疗反应.
- 为了确定最佳的生物标志物来跟踪口服双酸盐治疗的坚持和有效性.
主要方法:
- 研究了108名绝经后的妇女接受口服双酸盐 (阿伦德罗纳特,伊班德罗纳特,瑞塞德罗纳特) 两年.
- 在腰椎 (LSBMD) 和全部 (THBMD) 评估骨矿物质密度 (BMD).
- 测量的骨周转标记物:C端端 (CTX) 和第1类型的N端端 (PINP).
主要成果:
- 骨周转标记物 (CTX和PINP) 显示信号噪声比 BMD 的比率更高.
- 与LSBMD (47%) 和THBMD (24%) 相比,CTX (96%) 和PINP (94%) 的响应率超过最不显著的变化显著更高.
- "预期变化"方法证实CTX和PINP是可靠的响应标记,超过最不显著的变化.
结论:
- 骨循环标记 (CTX和PINP) 在监测口服双酸盐治疗时比BMD更有效.
- "预期变化"方法为评估治疗反应提供了一个生物学相关的终点.
- 优化的监测策略对于管理骨质疏松症和确保治疗坚持是必不可少的.
相关概念视频
01:26Oral Drug Delivery Systems: Continuous-Release Systems
58
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
58
01:28IV Infusion to Oral Dosing: Conversion Methods
47
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
47
01:28Urinary Tract Calculi V: Nursing Management
358
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
358